期刊
JOURNAL OF NUCLEAR MEDICINE
卷 51, 期 6, 页码 973-977出版社
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.109.074310
关键词
nephrotoxicity; In-111; renal reabsorption; radiolabeled peptide; dosimetry
资金
- KWF/NKB (Dutch Cancer Foundation) [EMCR 2007-3758]
We determined the renal radiation dose of a series of In-111-labeled peptides using animal SPECT. Because the animals' health deteriorated, renal toxicity was assessed. Methods: Wild-type and megalin-deficient mice were imaged repeatedly at 3- to 6-wk intervals to quantify renal retention after injection of 40-50 MBq of In-111-diethylenetriaminepentaacetic acid-labeled peptides (octreotide, exendin, octreotate, neurotensin, and minigastrin analogs), and the absorbed kidney radiation doses were estimated. Body weight, renal function parameters, and renal histology were determined at 16-20 wk after the first scan and compared with those in naive animals. Results: Because of high renal retention, In-111-diethylenetriaminepentaacetic acid-exendin-4 scans resulted in a 70-Gy kidney radiation dose in wild-type mice. Megalin-deficient kidneys received 20-40 Gy. The other peptides resulted in much lower renal doses. Kidney function monitoring indicated renal damage in imaged animals. Conclusion: Micro-SPECT enables longitudinal studies in 1 animal. However, long-term nephrotoxic effects may be induced after high renal radiation doses, even with In-111-labeled radiotracers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据